Presented positive updated data from the ALLOHA™ Phase 1 heme trial at 67th American Society of Hematology (ASH) Annual Meeting…
Company to Host Conference Call at 8:30am ET March 04, 2026 07:00 ET | Source: Kamada Ltd. REHOVOT, Israel, and…
Outpatient treatment enabled under FT819-102 autoimmune basket protocol with patients now treated with FT819 off-the-shelf CAR T-cell therapy as same-day…
February 20, 2026 17:16 ET | Source: Constellation Software Inc. TORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Constellation Software Inc.…
February 19, 2026 08:05 ET | Source: GigaCloud Technology EL MONTE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- GigaCloud Technology…
US$82 Million in Pending Proposals Across Multiple Infectious Disease Programs US$40 Million NIAID Funding Award Supports VXV-01 Development Through Phase…
Oslo, Norway, 12th of February 2026 Vistin Pharma ASA (VISTN) today announces the financial results for the fourth quarter and…
Company Reaches Settlements in Two Separate Pending Litigation Cases to Resolve Large Portion of Potential Financial Liability February 06, 2026…
February 05, 2026 07:01 ET | Source: BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., Feb. 05, 2026 (GLOBE NEWSWIRE) --…
February 04, 2026 05:00 ET | Source: ChipMOS TECHNOLOGIES INC. HSINCHU, Taiwan, Feb. 04, 2026 (GLOBE NEWSWIRE) -- ChipMOS TECHNOLOGIES…